The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,974.00
Bid: 2,972.00
Ask: 2,974.00
Change: 24.00 (0.81%)
Spread: 2.00 (0.067%)
Open: 2,947.00
High: 2,979.00
Low: 2,934.00
Prev. Close: 2,950.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Sep 2016 09:33

RNS Number : 1849J
3i Group PLC
07 September 2016
 

 

3i Group plc: non-executive Director change

 

Stephen Daintith

3i Group plc announces the appointment of Stephen Daintith as a non-executive Director with effect from 1 October 2016.

 

Stephen Daintith has been Finance Director of Daily Mail and General Trust plc ("DMGT") since January 2011. Prior to joining DMGT he was Chief Operating Officer and Chief Financial Officer of Dow Jones and prior to that Chief Financial Officer of News International. He originally qualified as a Chartered Accountant with Price Waterhouse (now part of PwC). He is also a non-executive director at Zoopla Property Group plc.

 

Simon Thompson, 3i Chairman, said: "We are very pleased to announce Stephen's appointment to 3i's Board. He brings directly relevant financial and operating experience across a range of consumer, digital and other international businesses."

 

Stephen Daintith commented: "I am excited to be joining the Board of 3i as the firm continues to focus on successfully executing its strategic plan and generating shareholder value. 3i has a strong management team and is well placed to take advantage of a considerable market opportunity."

 

There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.

 

 

-Ends-

 

For further information, contact:

Toby Bates 020 7975 3032

Communications Director

 

Silvia Santoro 020 7975 3258

Investor Relations Director

 

Notes to Editors:

 

About 3i

 

3i is an investment company with three complementary businesses, Private Equity, Infrastructure and Debt Management, specialising in core investment markets in northern Europe and North America. For further information, please visit: www.3i.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALRMPTMBJMMBF
Date   Source Headline
18th Jun 20209:00 amRNSDirector/PDMR Shareholding
11th Jun 202010:39 amRNSBlock listing Interim Review
10th Jun 20202:52 pmRNSDirector/PDMR Shareholding
3rd Jun 20201:30 pmRNSDirector/PDMR Shareholding
3rd Jun 202012:00 pmRNSPublication of a Prospectus
29th May 20204:03 pmRNSTotal Voting Rights
29th May 20204:02 pmRNSDirector/PDMR Shareholding
29th May 202010:37 amRNSDTR 6.3.5
27th May 202011:04 amRNSDoc re. 2020 Notice of AGM
20th May 202010:55 amRNSDoc re. 2020 Annual Report and Accounts
14th May 20207:00 amRNSResults for the year to 31 March 2020
30th Apr 20203:09 pmRNSTotal Voting Rights
30th Apr 20203:08 pmRNSDirector/PDMR Shareholding
1st Apr 202010:02 amRNSDirector/PDMR Shareholding
30th Mar 20209:39 amRNSDirector/PDMR Shareholding
30th Mar 20209:38 amRNSDirector/PDMR Shareholding
19th Mar 20208:30 amRNSCovid-19 update and Action Seminar
10th Mar 20202:28 pmRNSHolding(s) in Company
28th Feb 20204:10 pmRNSTotal Voting Rights
28th Feb 20204:07 pmRNSDirector/PDMR Shareholding
20th Feb 202011:30 amRNSHolding(s) in Company
4th Feb 20203:56 pmRNSHolding(s) in Company
31st Jan 20204:18 pmRNSTotal Voting Rights
31st Jan 20204:15 pmRNSDirector/PDMR Shareholding
30th Jan 20207:00 amRNSFY2020 Q3 Performance update
7th Jan 202011:51 amRNSPortfolio Update
3rd Jan 20203:18 pmRNSTotal Voting Rights
3rd Jan 20203:15 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:47 amRNSDirectorate Change
17th Dec 20194:02 pmRNSDirector/PDMR Shareholding
11th Dec 201910:48 amRNSBlock listing Interim Review
3rd Dec 201912:00 pmRNSDirector/PDMR Shareholding
29th Nov 20193:17 pmRNSTotal Voting Rights
29th Nov 20193:13 pmRNSDirector/PDMR Shareholding
14th Nov 20191:39 pmRNSDoc re. Half Yearly Report 2019
14th Nov 20197:00 amRNSHalf-year Report
31st Oct 20192:52 pmRNSTotal Voting Rights
31st Oct 20192:51 pmRNSDirector/PDMR Shareholding
1st Oct 20193:44 pmRNSPortfolio Update
30th Sep 20193:01 pmRNSTotal Voting Rights
30th Sep 20192:52 pmRNSDirector/PDMR Shareholding
23rd Sep 201911:55 amRNSDirector/PDMR Shareholding
18th Sep 20199:00 amRNSPrivate Equity Capital Markets Seminar
2nd Sep 201912:12 pmRNSDirector Declaration
30th Aug 20193:37 pmRNSTotal Voting Rights
30th Aug 20193:36 pmRNSDirector/PDMR Shareholding
21st Aug 20194:22 pmRNSHolding(s) in Company
21st Aug 20199:09 amRNSAdditional Listing
2nd Aug 201910:36 amRNSDirector/PDMR Shareholding
1st Aug 20193:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.